10x (TXG) - Uzoq muddatli qarzning kapitalga nisbati
10x Genomics, Inc. (TXG) ekologik toza sintez usullarini va biologik parchalanuvchi qadoqlarni joriy qilmoqda, biroq tadqiqot grantlarining kamayishi va kuchaygan raqobat uning narxlarni belgilash imkoniyatlarini zaiflashtirmoqda. Ushbu narxlar grafigi shuni ko'rsatadiki, yakka tartibdagi uzoq muddatli qarzdorlikning kapitalga nisbati 0.08 darajasida turibdi. 10x Genomics, Inc. (TXG) barqarorligi sog'liqni saqlash gigantlarining hujayralarni tahlil qilish uskunalariga bo'lgan talabi va mustahkam patent himoyasiga bog'liq.
%20Uzoq%20muddatli%20qarzning%20kapitalga%20nisbati&width=1200&height=400&colorIndex=0&v=mvujvhid.si-7ayy9s0&start=20220704&end=20261030&filename=GURU_Markets_-_TXG_-_10x-Genomics-Inc._-_Long-Term-Debt-to-Capital "TXG: 10x Genomics Inc Uzoq muddatli kreditlarning kapitalga nisbati 04.07.2022 - 30.10.2026 | 👁️GURU.Markets👁️")
10x Genomics, Inc. (TXG) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi ko'rsatkichlari:
- kompaniyaning balans qiymati tafsilotlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Barcha qarzlarning o‘z mablag‘lariga nisbati 10x Genomics, Inc.|TXG - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzdorlikning o'z kapitaliga nisbati 10xgenomics.com|TXG - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar 10x Genomics, Inc.|TXG - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi 10x Genomics|Shoshilinch likvidlik 10xgenomics.com
- foyda va qiymat multiplikatorlari haqida ma'lumot:
Kompaniyaning jamlanma tahlili:TXG (10x Genomics Inc)
Ushbu ko'rsatkich kapital tuzilmasidagi uzoq muddatli majburiyatlarning ulushini o'lchaydi, bu esa kompaniyaning kredit risklariga chidamliligini va moliyaviy leverajning samaradorligini baholash imkonini beradi. Uzoq muddatli qarzlarning kapitalga nisbati tahlili 10x Genomics, Inc. (TXG) uchun juda muhimdir, chunki Osiyodagi eksport cheklovlari daromadlarni kamaytirishi va haddan tashqari katta qarz yukini tizimli beqarorlik omiliga aylantirishi mumkin.
Raqobatdosh kompaniyalar tahlili
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi TEM (Tempus)|Uzoq muddatli qarzning kapitalga nisbati QGEN|Uzoq muddatli qarzning kapitalga nisbati Isis Pharmaceuticals (IONS)|Uzoq muddatli qarzning kapitalga nisbati RGEN (Repligen Corporation)|Uzoq muddatli kreditlarning kapitalga nisbati RNA (aviditybiosciences.com)|CRSP: Uzoq muddatli qarzning o'z kapitaliga nisbati|WGS (GeneDx Holdings) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|RARE (Ultragenyx Pharma) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Beam Tx - Uzoq muddatli qarzning kapitalga koeffitsiyenti|SRPT (Sarepta Therapeutics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|TWST - Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati NTLA|STOK - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati BioLife Corp BLFS|WVE: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|MAZE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati sionnatx.com|Prime Medicine (PRME) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Taysha Gene Therapies Inc|QURE (uniQure Corp) - Uzoq muddatli qarzning kapitalga nisbati|MeiraGTx Corp (MGTX) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati RGNX|Uzoq muddatli qarzning o'z kapitaliga nisbati solidbio.com SLDB|Uzoq muddatli qarzning o'z kapitaliga nisbati Ocugen OCGN|Uzoq muddatli qarzdorlikning kapitalga nisbati Pacific Biosciences of California, Inc. (PACB)|BNTC: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti DSGN (Design Corp)|RCKT: Uzoq muddatli qarzning kapitalga nisbati|FDMT - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Lexeo Therapeutics Inc.|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi KRRO (Korro Bio, Inc)|Uzoq muddatli qarzning kapitalga nisbati EDIT|Uzoq muddatli qarzning o'z kapitaliga nisbati Silence Therapeutics Corp SLN|ProQR Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Codexis Inc (CDXS)|SGMO: Uzoq muddatli qarzning o'z kapitaliga nisbati|Nautilus Biotechnology - Uzoq muddatli kreditlarning kapitalga nisbati|MGX (Metagenomi, Inc) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi DTIL|GBIO (Generation Bio Co) - Uzoq muddatli qarzning kapitalga nisbati|BOLD - Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati XCUR|imunon.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning o'z kapitaliga nisbati Phio Pharmaceuticals Corp. PHIO|MBIO: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|TransCode - Uzoq muddatli qarzning kapitalga nisbati|BNGO - Uzoq muddatli qarzning kapitalga nisbati|APDN: Uzoq muddatli qarzning kapitalga nisbati|BLUE: Uzoq muddatli kreditlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati IPA|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi OMGA (Omega Therapeutics Corp)|Uzoq muddatli qarzning o'z kapitaliga nisbati OMIC (Singular Genomics Systems)|RGLS (regulusrx.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati SYRS (Syros Pharmaceuticals, Inc.)|Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati Telesis Bio Inc.|TRACON - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Unity Biotechnology, Inc